Viewpoint Molecular Targeting Competitors and Similar CompaniesClear all
Viewpoint Molecular Targeting's competitors and similar companies include Cell>Point and CIRS.
 Viewpoint Molecular Targeting Viewpoint Molecular Targeting is a radiopharmaceutical company that develops alpha-particle therapy for cancer. |  Cell>Point Cell>Point is a biotech company that develops and commercializes molecular imaging and targeted therapeutics. |  CIRS CIRS (also known as Computerized Imaging Reference Systems) is a company that manufactures tissue equivalent phantoms and simulators intended to improve upon existing tissue simulation methodology. | |
Founding Date | Founding Date 2008 | Founding Date 2001 | Founding Date 1982 |
Type | Type Subsidiary | Type Private | Type Private |
Tags | |||
Locations | Locations Coralville, US HQ | Locations Centennial, US HQ | Locations Norfolk, US HQ |
Employees | Employees 517% decrease | Employees 3 | Employees 254% decrease |
Funding | |||
Total funding raised | Total funding raised $ 300k | Total funding raised $ 23.7m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Cell>Point
HQ
Centennial, US
Employees
3
Cell>Point is a biotech company that develops and commercializes molecular imaging and targeted therapeutics.
View companyCIRS
HQ
Norfolk, US
Employees
25↓ 4% decrease
CIRS (also known as Computerized Imaging Reference Systems) is a company that manufactures tissue equivalent phantoms and simulators intended to improve upon existing tissue simulation methodology.
View company